Publisher
Orthonose SAS publishes OrthonoseLabs from Paris, France. Product names, including Orthonose®, are trademarks of Orthonose SAS.
Legal
Legal notice
This website is published by Orthonose SAS, Paris, France, for general information about its research program.
Not medical advice
Nothing here is medical advice, instructions for use, a diagnosis, or a treatment recommendation. A qualified clinician remains responsible for clinical decisions. Interceptive statements refer to piloted use, not a consumer product.
Regulatory and clinical status
CE Class I and IIa in Europe; ANSM declaration filed. Patient-specific. US Class I classification. This website does not claim a current FDA listing, clearance or approval. Regulatory status, labelling, indications and availability vary by jurisdiction. No registration, clearance, approval or marketing authorisation is claimed for any territory except as stated here. Preliminary evidence: a small, non-randomized proof-of-concept series. Larger independent studies and follow-up through nasal maturity are needed.
Governing law
These terms are governed by the laws of France. Subject to protections that cannot be waived, the courts of Paris have jurisdiction over disputes arising from this website.